MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future

Published:2024-03-15 Issue:3 Volume:76 Page:414-453
ISSN:0031-6997
Container-title:Pharmacological Reviews
language:en
Short-container-title:Pharmacol Rev

Author:

Wang Wei,Albadari Najah,Du Yi,Fowler Josef F.,Sang Hannah T.,Xian Wa,McKeon Frank,Li Wei,Zhou Jia,Zhang Ruiwen

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Reference321 articles.

1. Mdm2 Is Required for Survival of Hematopoietic Stem Cells/Progenitors via Dampening of ROS-Induced p53 Activity

2. Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study;Abdul Razak;Clin Cancer Res,2022

3. A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors;Abdul Razak;Invest New Drugs,2020

4. Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer;Adams;Cancer Discov,2023

5. Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?;Adashek;Trends Cancer,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade;Annals of Hematology;2024-09-12

2. Response by Shridhar et al to Letter Regarding Article, “MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy”;Circulation;2024-08-27

3. An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues;Cancer Letters;2024-08

4. Exploring Ubiquitin-specific proteases as therapeutic targets in Glioblastoma;Pathology - Research and Practice;2024-08

5. Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning;Molecules;2024-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3